These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
169 related articles for article (PubMed ID: 19359328)
1. Adiponectin is increased in cardiac cachexia irrespective of body mass index. Araújo JP; Lourenço P; Rocha-Gonçalves F; Ferreira A; Bettencourt P Eur J Heart Fail; 2009 Jun; 11(6):567-72. PubMed ID: 19359328 [TBL] [Abstract][Full Text] [Related]
2. Elevated adiponectin levels in patients with chronic heart failure: an independent predictor of mortality or a marker of cardiac cachexia? Celik T; Yaman H Int J Cardiol; 2010 Oct; 144(2):319-20. PubMed ID: 19304331 [TBL] [Abstract][Full Text] [Related]
3. Plasma adiponectin in heart failure with and without cachexia: catabolic signal linking catabolism, symptomatic status, and prognosis. Szabó T; Scherbakov N; Sandek A; Kung T; von Haehling S; Lainscak M; Jankowska EA; Rudovich N; Anker SD; Frystyk J; Flyvbjerg A; Pfeiffer AF; Doehner W Nutr Metab Cardiovasc Dis; 2014 Jan; 24(1):50-6. PubMed ID: 23791298 [TBL] [Abstract][Full Text] [Related]
4. Cross-talk between the heart and adipose tissue in cachectic heart failure patients with respect to alterations in body composition: a prospective study. Christensen HM; Kistorp C; Schou M; Keller N; Zerahn B; Frystyk J; Flyvbjerg A; Faber J Metabolism; 2014 Jan; 63(1):141-9. PubMed ID: 24140097 [TBL] [Abstract][Full Text] [Related]
5. Increase in serum adiponectin concentration in patients with heart failure and cachexia: relationship with leptin, other cytokines, and B-type natriuretic peptide. McEntegart MB; Awede B; Petrie MC; Sattar N; Dunn FG; MacFarlane NG; McMurray JJ Eur Heart J; 2007 Apr; 28(7):829-35. PubMed ID: 17403719 [TBL] [Abstract][Full Text] [Related]
6. Wasting of the left ventricle in patients with cardiac cachexia: a cardiovascular magnetic resonance study. Florea VG; Moon J; Pennell DJ; Doehner W; Coats AJ; Anker SD Int J Cardiol; 2004 Oct; 97(1):15-20. PubMed ID: 15336800 [TBL] [Abstract][Full Text] [Related]
7. Nuclear factor-kappaB activity in peripheral blood mononuclear cells in cachectic and non-cachectic patients with chronic heart failure. Siednienko J; Jankowska EA; Banasiak W; Gorczyca WA; Ponikowski P Int J Cardiol; 2007 Nov; 122(2):111-6. PubMed ID: 17270295 [TBL] [Abstract][Full Text] [Related]
8. Serum adiponectin, anemia and left ventricular dimensions in patients with cardiac cachexia. Bozcali E; Polat V; Akbulut H; Ferzeyn Yavuzkir M; Karaca I Cardiology; 2013; 126(4):207-13. PubMed ID: 24051989 [TBL] [Abstract][Full Text] [Related]
9. Adiponectin, ghrelin, and leptin in cancer cachexia in breast and colon cancer patients. Wolf I; Sadetzki S; Kanety H; Kundel Y; Pariente C; Epstein N; Oberman B; Catane R; Kaufman B; Shimon I Cancer; 2006 Feb; 106(4):966-73. PubMed ID: 16411208 [TBL] [Abstract][Full Text] [Related]
10. [Leptin serum levels in cachectic and non-cachectic lung cancer patients]. Weryńska B; Kosacka M; Gołecki M; Jankowska R Pneumonol Alergol Pol; 2009; 77(6):500-6. PubMed ID: 20013699 [TBL] [Abstract][Full Text] [Related]
12. New biochemical markers in chronic heart failure. el-Bindary EM; Darwish AZ East Mediterr Health J; 2001; 7(4-5):697-706. PubMed ID: 15332768 [TBL] [Abstract][Full Text] [Related]
13. Leptin and cardiac cachexia: marker or mediator? Cleland JG; Clark AL Eur Heart J; 1998 Oct; 19(10):1421-2. PubMed ID: 9820983 [No Abstract] [Full Text] [Related]
14. Fibrinogen synthesis is increased in cachectic patients with chronic heart failure. Witte KK; Ford SJ; Preston T; Parker JD; Clark AL Int J Cardiol; 2008 Oct; 129(3):363-7. PubMed ID: 18022259 [TBL] [Abstract][Full Text] [Related]
15. Plasma adiponectin, body mass index, and mortality in patients with chronic heart failure. Kistorp C; Faber J; Galatius S; Gustafsson F; Frystyk J; Flyvbjerg A; Hildebrandt P Circulation; 2005 Sep; 112(12):1756-62. PubMed ID: 16157772 [TBL] [Abstract][Full Text] [Related]
16. Disturbance of circulating ghrelin and obestatin in chronic heart failure patients especially in those with cachexia. Xin X; Ren AJ; Zheng X; Qin YW; Zhao XX; Yuan WJ; Guo ZF Peptides; 2009 Dec; 30(12):2281-5. PubMed ID: 19666068 [TBL] [Abstract][Full Text] [Related]
17. Total and high molecular weight adiponectin, haemodynamics, and mortality in patients with chronic heart failure. Tsutamoto T; Tanaka T; Sakai H; Ishikawa C; Fujii M; Yamamoto T; Horie M Eur Heart J; 2007 Jul; 28(14):1723-30. PubMed ID: 17507366 [TBL] [Abstract][Full Text] [Related]
18. [Serum ghrelin, IL-6 and TNF-α levels in patients with chronic obstructive pulmonary disease.]. Deveci Y; Deveci F; Ilhan N; Karaca I; Turgut T; Muz MH Tuberk Toraks; 2010; 58(2):162-72. PubMed ID: 20865569 [TBL] [Abstract][Full Text] [Related]
19. Ghrelin, adiponectin, and leptin do not predict long-term changes in weight and body mass index in older adults: longitudinal analysis of the Rancho Bernardo cohort. Langenberg C; Bergstrom J; Laughlin GA; Barrett-Connor E Am J Epidemiol; 2005 Dec; 162(12):1189-97. PubMed ID: 16236994 [TBL] [Abstract][Full Text] [Related]
20. Uric acid in cachectic and noncachectic patients with chronic heart failure: relationship to leg vascular resistance. Doehner W; Rauchhaus M; Florea VG; Sharma R; Bolger AP; Davos CH; Coats AJ; Anker SD Am Heart J; 2001 May; 141(5):792-9. PubMed ID: 11320368 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]